We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+15.3%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$1.36B
Cap. Flow
+$146M
Cap. Flow %
1.38%
Top 10 Hldgs %
29.42%
Holding
618
New
18
Increased
256
Reduced
279
Closed
53

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$40.3M
2
XOM icon
ExxonMobil
XOM
+$26.7M
3
TSLA icon
Tesla
TSLA
+$20.2M
4
AAPL icon
Apple
AAPL
+$14.6M
5
COP icon
ConocoPhillips
COP
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 25.63%
2 Healthcare 13.36%
3 Consumer Discretionary 12.83%
4 Financials 12.67%
5 Communication Services 10.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
26
Netflix
NFLX
$326B
$69.8M 0.66%
1,291,500
-30,000
-2% -$1.52M
KO icon
27
Coca-Cola
KO
$380B
$67.8M 0.64%
1,237,116
-17,600
-1% -$910K
INTC icon
28
Intel
INTC
$516B
$64.1M 0.61%
1,287,013
+510,500
+66% +$24.9M
PFE icon
29
Pfizer
PFE
$157B
$61.4M 0.58%
1,669,311
-107,639
-6% -$3.95M
MRK icon
30
Merck
MRK
$354B
$61.1M 0.58%
783,389
-23,895
-3% -$1.83M
CRM icon
31
Salesforce
CRM
$214B
$60.3M 0.57%
271,097
+900
+0.3% +$219K
T icon
32
AT&T
T
$184B
$60.2M 0.57%
2,770,543
-64,214
-2% -$1.38M
PEP icon
33
PepsiCo
PEP
$185B
$59.2M 0.56%
399,230
-13,100
-3% -$1.86M
CSCO icon
34
Cisco
CSCO
$433B
$56.9M 0.54%
1,272,408
-10,000
-0.8% -$411K
ABBV icon
35
AbbVie
ABBV
$464B
$55.6M 0.53%
518,976
-20,400
-4% -$1.96M
TMO icon
36
Thermo Fisher Scientific
TMO
$236B
$54.9M 0.52%
117,776
-3,500
-3% -$1.64M
ABT icon
37
Abbott
ABT
$177B
$54.7M 0.52%
499,759
+180,000
+56% +$19.6M
NKE icon
38
Nike
NKE
$54.1B
$53.3M 0.51%
376,561
-3,100
-0.8% -$411K
AVGO icon
39
Broadcom
AVGO
$1.61T
$52.2M 0.49%
1,191,560
-43,000
-3% -$1.68M
COST icon
40
Costco
COST
$403B
$50.9M 0.48%
135,140
-300
-0.2% -$112K
QCOM icon
41
Qualcomm
QCOM
$201B
$50.6M 0.48%
332,355
-9,100
-3% -$1.27M
ACN icon
42
Accenture
ACN
$121B
$50.5M 0.48%
193,294
+3,200
+2% +$767K
MDT icon
43
Medtronic
MDT
$121B
$48M 0.46%
409,762
+4,200
+1% +$462K
MCD icon
44
McDonald's
MCD
$180B
$46.3M 0.44%
215,862
-6,400
-3% -$1.39M
TXN icon
45
Texas Instruments
TXN
$241B
$44M 0.42%
268,060
+99,900
+59% +$15.5M
LLY icon
46
Eli Lilly
LLY
$1.02T
$43.1M 0.41%
255,516
+93,400
+58% +$13.9M
DHR icon
47
Danaher
DHR
$146B
$41.7M 0.4%
211,568
-12,295
-5% -$2.47M
BMY icon
48
Bristol-Myers Squibb
BMY
$130B
$41.5M 0.39%
668,455
-22,900
-3% -$1.41M
NEE icon
49
NextEra Energy
NEE
$170B
$41.3M 0.39%
535,060
-1,200
-0.2% -$89.8K
AMGN icon
50
Amgen
AMGN
$205B
$40.8M 0.39%
177,545
-5,400
-3% -$1.25M

Similar funds

Fjarde Ap-fonden's Q4 2020 Portfolio in Review

As of Q4 2020, Fjarde Ap-fonden held 618 positions worth $10.5B, up 15% from $9.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Fjarde Ap-fonden's Q4 2020 filing shows 18 new, 256 increased, 279 reduced and 53 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 79,100 shares worth $5.79M. The largest sale was Chevron, an estimated $40.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fjarde Ap-fonden's largest Q4 2020 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 79,100 shares worth $5.79M.
  • Fjarde Ap-fonden added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $169M increase.
  • Fjarde Ap-fonden's biggest Q4 2020 reduction was Tesla, cutting an estimated $20.2M.
  • Fjarde Ap-fonden fully exited Chevron in Q4 2020, selling an estimated $40.3M.
  • Fjarde Ap-fonden's ten largest holdings make up 29% of its $10.5B portfolio in Q4 2020.
  • Fjarde Ap-fonden opened 18 new positions and closed 53 in Q4 2020.
  • Fjarde Ap-fonden's portfolio value rose 15% quarter-over-quarter to $10.5B.

Based on Fjarde Ap-fonden's 13F filing for Q4 2020, filed 12 Feb 2021.